Astrazeneca, the EMA (European Medicines Agency) is again ruling on the Anglo-Swedish vaccine and says clearly that the benefits outweigh the risks. The opinion of the EMA silences the controversies, doubts and perplexities that have occurred in recent weeks regarding the alleged side effects caused by the vaccine in question. Meanwhile, the trend of the curve with regard to Covid infections throughout the peninsula is always under the lens of the experts.
According to the data released by Ministry of Health, in the last 24 hours, they registered 13.708 new positive cases (yesterday 7.767). The new deaths are 627 (yesterday 421); the discharged healed are 20.927 (yesterday 21.733). Overall, the positive cases are 547.837, 7.868 cheaper than yesterday. The swabs carried out are 339.939; in intensive care they are hospitalized 3.683 Covid patients. They also remain in home isolation 514.838 people infected with the virus.
Astrazeneca, more benefits than risks
"The benefits of the Astrazeneca vaccine outweigh the risks. Cerebral thrombosis events are very rare side effects". This was confirmed by EMA, the European drug agency. Experts also let it be known that “the information in the vaccine leaflet's Astrazeneca specific notices will be updated and will also be disseminated ". Furthermore, the director ofEma, emer cooke asserts that “The risk of mortality due to Covid is much greater than the risk of mortality due to side effects.
Consequences that can occur following vaccination. Side effects caused by vaccines are very rare - Cooke insists - We must emphasize the message that vaccines will help us in the fight against Covid. And we must continue to use them". Following Ema's latest pronouncement, an extraordinary meeting was called in video conference of EU health ministers. Vaccination campaigns in the countries of the European Union are on the agenda, in light of the new assessments on the Astrazeneca vaccine.
Hopefully we will be out of the tunnel in 6/8 weeks
"Swe are in the last half mile, vaccinating 300 people a day, we arrive at 25-30 million vaccinated and we will have the turning point. Hopefully in 6-8 weeks we are out of it exactly as we did in Great Britain".
These are the considerations of Sergio Abrignani, immunologist and member of the Technical Scientific Committee (Cts), interviewed by a national television broadcaster. The professor also stated that "Astrazeneca will also be administered to over 65s". Finally, according to Abrignani "the hypothesis of a second dose with another vaccine is also plausible".
